Company news

Clever Culture Systems Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Business Update Presentation

April 29, 2019

APAS Independence MRSA Study Results Presented at ECCMID

April 14, 2019

MRSA Analysis Module - Clinical Study Commenced

April 1, 2019

US FDA 510k Submitted for APAS Independence

December 20, 2018

LBT Presentation - 121 Tech Investment Conference, Singapore

December 2, 2018

CEO Presentation - AGM 2018

November 28, 2018

First Placement of APAS Independence into US Lab

November 25, 2018

Quarterly Activities & Cashflow Report - Appendix 4C

October 30, 2018

Company Presentation - Australian Non Deal Roadshow

September 16, 2018

Preliminary Final Report

August 30, 2018

Finalisation of SA Government Loan Facility Agreement

August 27, 2018

First Commercial Sale of APAS Independence

August 21, 2018

Quarterly Activities & Cash Flow Report - Appendix 4C

July 30, 2018

Market Update

June 28, 2018

Strategic Plan & Asset Review, WoundVue

June 5, 2018

First Placement of APAS Independence into European Lab

April 24, 2018

Share Purchase Plan Offer Document

March 14, 2018

$7m Oversubscribed Private Placement & Launch of $1m SPP

March 5, 2018

LBT Receives $4m Funding from South Australian Government

February 18, 2018

Quarterly Activities & Cash Flow Report (Appendix 4C)

January 29, 2018

$2.5M Grant Awarded to Advance WoundVue Development

December 6, 2017

Completion of Transaction with Autobio

December 1, 2017

St Vincents Hospital Completes APAS Independence Evaluation

November 28, 2017

Autobio $2M Placement in LBT & MicroStreak IP Transfer

October 27, 2017

LBT Receives $4.2 Million in R&D Incentives

October 9, 2017

ST Vincents Hospital Commences APAS Automated Evaluation

September 26, 2017

LBTs WoundVue Prototype to be used at CALHN

August 8, 2017

CE Mark Self Certification Finalised for APAS

June 22, 2017

St vincents Hospital melbourne to be first APAS trial site

June 20, 2017

LBT Appointed Distributor for Australia and New Zealand

June 14, 2017

Share Purchase Plan Offer

May 23, 2017

APAS included on the Australian TGA register

March 27, 2017

Completion of Placement

December 1, 2016

LBT Innovations Granted New Patent for United States

November 10, 2016

US FDA grants approval for APAS

October 9, 2016

LBT granted patent in Japan for core APAS technology

May 19, 2016

Cochlear Executive Brent Barnes Appointed CEO of LBT

May 9, 2016

LBT Receives Notice of Allowance for Third Patent

April 6, 2016

LBT Begins Clinical Trials of APAS Technology

March 30, 2016

LBT Innovations Completes U.S. Regulatory Submission

February 11, 2016

LBT Concludes APAS Clinical Trial Program

February 10, 2016

← Newer news releases

Decks

The 5 newest of 12 decks. Every deck is listed under its year.